Clinical trial
Befotertinib and Icotinib for NSCLC With Uncommon EGFR Mutations
NCT06517953
Study timeline
Study start (actual)2024-07-17Date precision: day
Registry last updated2024-07-25
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Non-small Cell Lung Cancer Metastaticunresolved
EGFR G719Xunresolved
EGFR L861Qunresolved
EGFR S768Iunresolved
Interventions
IcotinibDRUG
BefotertinibDRUG
Sponsors & collaborators
Sun Yat-sen Universitylead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT06517953 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.